Lung Cancer Study Group

I have lung cancer. Should I be vaccinated against the flu? – GECP and PULMONALE join to answer all your questions questions

At the beginning of each vaccination season, lung cancer patients frequently have doubts about whether it is beneficial and safe to get the flu vaccine. This year, the COVID-19 pandemic has brought even more uncertainties on this topic. For this…

Read More

TERAVOLT reveal that patients with malignant thoracic tumors have a high risk of mortality from COVID 19

The Thoracic Cancers International COVID 19 Collaboration, also known as TERAVOLT, is an international consortium that was created to understand the impact of COVID-19 on patients with thoracic malignancies. Made up of medical experts from leading institutions around the world,…

Read More

On the International Day for the Elderly, GECP addresses the challenges in the treatment of lung cancer in geriatric age

The International Day of the Elderly is celebrated annually on the 1st of October. The western population is gradually aging. It is estimated that in 2050 28% of the European population is over 65, posing multiple economic, social and also…

Read More

”Advances in therapy in lung cancer are reflected in reduced mortality”

Dr.ª Gabriela Fernandes reveals an article published in the New England newspaper thatdemonstrates that innovations in the treatment of lung cancer are reflected in the reduction of mortality at the population level. Watch the video:  

Read More

In European lung cancer week, GECP warns of inequalities in access to treatment between different countries in Europe

The European Lung Cancer Week is celebrated annually between 14th and 20th September. On this occasion, the GECP intends to warn of disparities in access to diagnosis and treatment among lung cancer patients in different countries in Europe. To this…

Read More

The ESMO Congress is approaching, this year in a 100% virtual format

Each year the ESMO (European Society for Medical Oncology) congress attracts an international community of specialists in various disciplines, all focused on finding the best solutions currently available in the treatment of cancer. It usually gathers close to 30,000 participants…

Read More

Abstracts submission for the virtual “2020 IASLC World Conference on Lung Cancer” runs until August 28

The International Association for the Study of Lung Cancer (IASLC) holds the “2020 IASLC World Conference on Lung Cancer” (WCLC) in a fully virtual format. This important world conference, which annually brings together specialists in the treatment of lung cancer,…

Read More

Virtual Presidential Symposium anticipated the “2020 IASLC World Conference on Lung Cancer”

In the sequence of the postponement of the “2020 IASLC World Conference on Lung Cancer” to the beginning of next year, the International Association for the Study of Lung Cancer (IASLC) promoted on August 8th a Virtual Presidential Symposium, which…

Read More

On World Lung Cancer Day, GECP launches campaign “Let’s end stigma”

  To mark the World Day of Lung Cancer, annually celebrated on the 1st of August, GECP simultaneously launches a new campaign on social networks, and a new tab on the website, dedicated to the theme of stigma around lung cancer. This…

Read More

GECP launches campaign “Lung Cancer does not wait for the Pandemic to pass”

The GECP is promoting an alert campaign on social networks, aiming to combat the delay in using health services in the face of suspected lung cancer symptoms, in the current context of the COVID-19 pandemic. This initiative arises from the…

Read More
Don`t copy text!